Table 2.
LonP1 | CDDO IC50 (μM) | Fold increase in inhibition compared with WT |
---|---|---|
WT | 14.0 ± 2 | - |
F547A | 5.9 ± 0.6 ∗∗ | 2.4 |
C576V | 5.2 ± 1.5 ∗∗ | 2.7 |
C637V | 3.7a | 3.8 |
F547A/C576V | 1.8 ± 0.8 ∗∗∗ | 7.8 |
F547A/C637V | 1.9 ± 0.3 ∗∗∗ | 7.4 |
C576S | 11.9a | 1.2 |
C637S | 3.0a | 4.7 |
IC50 values were determined from end-point ATPase assays. They were derived from the best-fit dose–response curves and are reported as the mean ± S.D. of independent experiments (N ≥ 2) except for a where N = 1. (∗∗p < 0.01, ∗∗∗p < 0.001 by Tukey–Kramer multiple comparison test).